Everyone will tell you that exercise is healthy. But why? Let's find out.
![]()
Scientific illustration showing the organization of muscle fibers, highlighting the different fiber types discussed in this article.
The first reason is that exercise stimulates the production and maintentance of muscle, which wastes as we age and is crucial for autonomy and quality of life.
The second is that skeletal muscle is an endocrine organ that secretes myokines regulating whole‑body metabolism. Aging preferentially erodes fast fibers and neuromuscular function; training counteracts these changes [1][2][3][4][5][6].

A scientific illustration demonstrating how exercise triggers the release of myokines from skeletal muscle, illustrating the body's complex metabolic response to physical activity.
| Mechanism | Primary effect | Key outcomes | Evidence |
|---|---|---|---|
| Preserve muscle mass and strength | Slows sarcopenia (age‑related muscle loss) | Maintains mobility, lowers disability and mortality risk | Observational cohorts; RCTs with hypertrophy/strength gains [4:1][5:1][6:1] |
| Endocrine signaling (myokines) | IL‑6, irisin, myostatin, IL‑15, BDNF, FGF21, BAIBA, METRNL, myonectin, SPARC, decorin, apelin | Improves insulin sensitivity, lipid oxidation, adipose browning, inflammation resolution, tissue repair | Mechanistic, human acute exercise, RCT/controlled studies [1:1][2:1][3:1][7][8][9][10][11][12][13][14][15][16][17] |
| Fiber‑type and neuromuscular preservation | Counteracts preferential atrophy/denervation of type II fibers | Maintains power, reduces falls risk, supports functional independence | Histology, longitudinal physiology, intervention trials [4:2][18][5:2] |
Sarcopenia is the progressive loss of skeletal muscle mass, strength, and function with aging; it predicts disability, falls, and mortality [1:2][4:3]. Quantitatively, strength declines faster than mass (quality changes), e.g., longitudinal cohorts report marked losses in strength and muscle quality over time [4:4].
Resistance training in older and very old adults produces large, clinically meaningful gains in strength and fiber cross‑sectional area (CSA), demonstrating reversibility even in frailty [5:3][6:2].
Minimal numbers (illustrative):
Skeletal muscle secretes cytokines/peptides (myokines) into circulation during and after contraction, acting in autocrine/paracrine/endocrine fashions to regulate glucose and lipid metabolism, browning of adipose tissue, inflammation resolution, tissue repair, and brain function [1:3][2:2][3:2][7:1].
| Myokine (acronym expanded once) | Principal actions | Typical context | Evidence |
|---|---|---|---|
| Interleukin‑6 (IL‑6) | Increases glucose uptake and fatty‑acid oxidation in muscle; lipolysis; anti‑inflammatory signaling acutely during exercise | Acute exercise → transient rise | Mechanistic and human exercise studies [1:4][12:1] |
| Irisin (cleaved from FNDC5) | Induces browning of white adipose tissue; increases thermogenesis and energy expenditure | Endurance/resistance exercise | Nature discovery; human observational/intervention data [8:1][13:1] |
| Myostatin (GDF‑8) | Negative regulator of muscle growth; inhibition → hypertrophy | Basal regulation; reduced with training | Genetic/mechanistic; translational relevance [19] |
| Interleukin‑15 (IL‑15) | Supports muscle anabolism; associated with lower adiposity | Exercise‑responsive | Human/biological studies [7:2][16:1] |
| Brain‑derived neurotrophic factor (BDNF) | Increases fat oxidation via AMPK; muscle–brain axis (neurotrophic) | Muscle contraction; endurance exercise | Mechanistic and human cell work [9:1][7:3] |
| Fibroblast growth factor‑21 (FGF21) | Improves insulin sensitivity; regulates glucose/lipid metabolism | Acute and chronic exercise; metabolic stress | Human/mouse exercise/physiology [14:1][20] |
| β‑Aminoisobutyric acid (BAIBA) | Promotes hepatic β‑oxidation; induces browning of white fat | Exercise‑induced metabolite | Human associations; mechanistic data [10:1] |
| Meteorin‑like (METRNL) | Enhances beige fat thermogenesis; immune–adipose interactions | Cold/exercise | Cell and animal work with translational relevance [11:1] |
| Myonectin (CTRP15) | Increases fatty‑acid uptake; activates mTOR; suppresses hepatic autophagy | Exercise/muscle contraction | Mechanistic and in vivo studies [15:1][16:2] |
| Secreted protein acidic and rich in cysteine (SPARC) | Metabolic effects; exercise‑linked antitumorigenic signaling in colon | Regular exercise | Human tissue and animal mechanistic data [17:1] |
| Decorin | Binds/inhibits myostatin; contributes to hypertrophy | Resistance exercise | Human/animal mechanistic studies [21] |
| Apelin | Improves muscle function/regeneration; favorable metabolic effects | Aerobic training; aging muscle | Human cohort/intervention data [17:2] |
Notes: Acute IL‑6 elevations during exercise differ from chronic low‑grade inflammation; context (timing/tissue) determines net effect [1:5][12:2]. Evidence spans mechanistic, human acute exercise, and controlled training studies; not all myokines have definitive clinical outcome trials yet [2:3][7:4][22][23].
Schematic illustrating the preferential loss of Type II (fast-twitch) muscle fibers compared to Type I (slow-twitch) fibers over the human lifespan. While Type I fibers remain relatively stable, Type II fibers undergo significant atrophy and loss starting in mid-life. Modeled after data from Lexell et al. [18:1]
Human skeletal muscle comprises two primary fiber types: Type I (slow-twitch), which are fatigue-resistant and used for endurance; and Type II (fast-twitch), which generate high force and power but fatigue quickly. Aging does not affect these fibers equally.